Epidemiology of healthcare-associated SARS-CoV-2 outbreaks in Germany between March 2020 and May 2022

Suwono, Beneditta; Brandl, Michael; Hecht, Jane; Eckmanns, Tim; Haller, Sebastian

doi:10.1016/j.jhin.2023.01.011

Cited by 9 publications

(7 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nosocomial SARS-CoV-2 Omicron infections remain common, with crude mortality estimates ranging from 3% to 13%. 3,6 2022. Accessed January 11, 2023. https://phw.nhs.wales/services-and-teams/ harp/nosocomial-covid-briefing-reports/all-cause-mortality-in-nosocomialcovid-19-cases-in-wales-version-12…”

Section: Admission Testing Endsmentioning

confidence: 99%

“…This definition is similar to the broad definitions provided in other studies. [1][2][3] We reported 2019 estimates of primary care spending, total spending, percentage of medical spending on primary care visits, and percentage with 0 spending on primary care visits. We analyzed race and ethnicity data to test whether primary care spending was greater in some…”

Section: Primary Care Spending In the Us Populationmentioning

confidence: 99%

“…Polymerase chain reaction testing was recommended for admission testing during most of the study period. Hospital-onset SARS-CoV-2 infection rates closely correlate with community prevalence, 3 so we calculated weekly rates of new hospital-onset cases per 1000 community infections to assess the relative increases in hospital-onset cases. We used the UK Office for National Statistics (ONS) COVID-19 Infection Survey to estimate community prevalence.…”

mentioning

confidence: 99%

“…Nosocomial SARS-CoV-2 Omicron infections remain common, with crude mortality estimates ranging from 3% to 13%. 3,6 Hospitals should exercise caution before stopping universal admission testing for SARS-CoV-2 infections.…”

mentioning

confidence: 99%

See 3 more Smart Citations

Discontinuation of Universal Admission Testing for SARS-CoV-2 and Hospital-Onset COVID-19 Infections in England and Scotland

Pak,

Rhee,

Wang

et al. 2023

JAMA Intern Med

View full text Add to dashboard Cite

show abstract

Section: Admission Testing Endsmentioning

confidence: 99%

Section: Primary Care Spending In the Us Populationmentioning

confidence: 99%

mentioning

confidence: 99%

mentioning

confidence: 99%

See 2 more Smart Citations

Discontinuation of Universal Admission Testing for SARS-CoV-2 and Hospital-Onset COVID-19 Infections in England and Scotland

Pak,

Rhee,

Wang

et al. 2023

JAMA Intern Med

View full text Add to dashboard Cite

show abstract

“…Mortality rates were extremely high for hospital-acquired COVID-19 early in the pandemic, driven in part by especially poor outcomes in elderly and immunocompromised patients. [24,25] The morbidity and mortality associated with both community and hospitalacquired SARS-CoV-2 infections have steadily declined over time, yet even in the Omicron era crude mortality rates reported for hospital-acquired SARS-CoV-2 infections range from 3-13% [24,[26][27][28][29].…”

Section: Hospital-acquired Sars-cov-2 Infections Still Cause Substant...mentioning

confidence: 99%

In Support of Universal Admission Testing for SARS-CoV-2 During Significant Community Transmission

Rhee¹,

Pak²,

Köhler³

2023

Preprint

View full text Add to dashboard Cite

Many hospitals have stopped or are considering stopping universal admission testing for SARS-CoV-2. We discuss reasons why admission testing should still be part of a layered system to prevent hospital-acquired SARS-CoV-2 infections during times of significant community transmission. These include the morbidity of SARS-CoV-2 in vulnerable patients, the predominant contribution of presymptomatic and asymptomatic people to transmission, the high rate of transmission between patients in shared rooms, and the data suggesting surveillance testing is associated with fewer nosocomial infections. Preferences of diverse patient populations, particularly the hardest hit communities, should be surveyed and used to inform prevention measures. Hospitals’ ethical responsibility to protect patients from serious infections should predominate over concerns about costs, labor, and inconvenience. We call for more rigorous data on the incidence and morbidity of nosocomial SARS-CoV-2 infections and more research to help determine when to start, stop, and restart universal admission testing and other prevention measures.

show abstract

Impact of COVID-19 on healthcare-associated infections and antimicrobial use in Italy, 2022

Vicentini,

Russotto,

Bussolino

et al. 2024

Journal of Hospital Infection

View full text Add to dashboard Cite

Epidemiology of healthcare-associated SARS-CoV-2 outbreaks in Germany between March 2020 and May 2022

Cited by 9 publications

References 29 publications

Discontinuation of Universal Admission Testing for SARS-CoV-2 and Hospital-Onset COVID-19 Infections in England and Scotland

Discontinuation of Universal Admission Testing for SARS-CoV-2 and Hospital-Onset COVID-19 Infections in England and Scotland

In Support of Universal Admission Testing for SARS-CoV-2 During Significant Community Transmission

Impact of COVID-19 on healthcare-associated infections and antimicrobial use in Italy, 2022

Contact Info

Product

Resources

About